MARKET WIRE NEWS

Why I Wouldn't Touch Tilray Brands Stock With a 10-Foot Pole

Source: Motley Fool

2026-03-18 09:35:00 ET

Is Tilray Brands (NASDAQ: TLRY) finally bouncing back? After years of poor performance, the stock has climbed 7% over the past 12 months, which isn't bad by its standards. What's more, the market cheered the company's latest financial results. And with regulatory progress in the U.S. cannabis market, some see a bright future ahead for the pot grower. However, Tilray Brands still isn't worth investing in, not even close, in my view. Here's why I'd advise anyone to stay far away.

Image source: Getty Images.

Tilray's financial results over the past five years have been terrible, with slow or non-existent revenue growth, inconsistent margins, and consistent net losses. By now, anytime the company releases a quarterly update, expectations aren't particularly high. That's why even pretty modest results can send the stock price soaring . True, Tilray's latest earnings report, for the second quarter of its fiscal year 2026, ending on Nov. 30, showed some signs of improvement. The company's revenue of $217.5 million was a record for this period.

Continue reading

Tilray Brands Inc.

NASDAQ: TLRY

TLRY Trading

-4.53% G/L:

$6.325 Last:

1,560,711 Volume:

$6.63 Open:

mwn-alerts Ad 300

TLRY Latest News

TLRY Stock Data

$919,789,275
115,543,810
1.5%
97
N/A
Pharmaceuticals
Healthcare
US
Leamington

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App